Surgery – Instruments – Cyrogenic application
Reexamination Certificate
1999-01-12
2001-09-18
Gibson, Roy (Department: 3739)
Surgery
Instruments
Cyrogenic application
C606S023000, C606S007000
Reexamination Certificate
active
06290696
ABSTRACT:
Conventional angioplasty has been preformed for several decades, prolonging the lives of an ever increasing number of patients. Angioplasty procedures involves the dilatation of a balloon placed across a lesion in a coronary artery. Dilatation of the balloon in turn dilates the lesion, opening the artery for increased blood flow. In some cases, however, the goal of the angioplasty procedure is, in whole or in part, frustrated by complete or partial reclosure of the artery at the lesion. Two mechanisms are believed to be principally responsible for reclosure of the artery, these are restenosis and recoil. Restenosis is believed to be caused by continued growth or regrowth of the smooth muscle cells associated with the lesion. Recoil is in part a mechanical process involving elastic rebound of the dilated lesion.
Several means have been disclosed for addressing the problem of restenosis. These include, among others, radiation treatments to slow or prevent smooth muscle cell proliferation associated with the restenotic process. Certain drug therapies have been proposed to prevent or slow restenosis.
Several means have also been developed to address the issue of recoil. One of the more significant developments in this area has been stents, which can be permanently deployed to mechanically hold open lesions. Although stents have been found to be highly effective, they may irritate the wall of a artery in which they are implanted. Some believe that this may encourage limited restenosis. Warming of the lesion during dilatation has also been disclosed to prevent or slow recoil. Warming the lesion is believed to soften the lesions such that it may be “remodeled” that is, thinned under low pressure. Heating of the lesion, however, is believed to cause an injury response which may cause some restenosis.
SUMMARY OF THE INVENTION
The present invention is directed at an apparatus and method for performing angioplasty and preventing or slowing the post-procedure reclosure of a dilated lesion. The present invention cools the lesion to prevent or slow reclosure by the mechanisms of restenosis or recoil. A cryoplasty catheter is provided to cool the lesion to aid in remodeling the lesion to prevent or slow recoil. The present invention can also be used to cool the lesion to freeze a portion of the lesion tissue. This is believed to kill cells within the lesion which would promote restenosis.
A preferred embodiment of the cryoplasty catheter in accordance with the present invention includes a shaft having proximal and distal ends. The shaft defines an inflation lumen, coolant intake lumen and exhaust lumen therethrough. Each lumen has a proximal and distal end proximate the proximal and distal ends of the shaft respectively. A dilatation balloon is disposed at the distal end of the shaft and is in fluid communication with the inflation lumen. A chamber is disposed within the balloon and is in fluid communication with the intake and exhaust lumens. A source of coolant is connected to the proximal end of the shaft in fluid communication with the coolant intake lumen.
A thermo-resistive sensor can be disposed on the dilatation balloon to monitor the temperature of the lesion. A second thermo-resistive sensor can be disposed on the shaft to provide a control temperature reading.
In another preferred embodiment of the cryoplasty catheter in accordance with the present invention, the cryoplasty catheter includes a shaft having proximal and distal ends. The shaft defines an inflation lumen and a drain lumen therethrough. Each lumen has a proximal and a distal end proximate the proximal and distal ends of the shaft respectively. A dilatation balloon is disposed at the distal end of the shaft and is in fluid communication with the inflation and drain lumens. The cryoplasty catheter also includes a coolant source connected to the proximal end of the shaft in fluid communication with the inflation lumen.
This embodiment of the cryoplasty catheter can also include a thermo-resistive sensor disposed on the dilatation balloon. As well as the thermo-resistive sensor disposed on the balloon, a control sensor can be disposed on the catheter shaft.
A method of performing cryoplasty is also provided which includes the steps of advancing a cryoplasty catheter across a lesion, inflating the dilatation balloon to dilate the lesion, and delivering coolant to the balloon to cool the lesion. To aid in remodeling, the lesion adjacent the balloon can be cooled to between 10° C. and −10° C. A portion of the lesion adjacent the balloon can also be frozen to kill cells within the lesion which would otherwise promote restenosis. For enhanced effectiveness, freezing may be done by flash freezing the tissue for 20 to 60 seconds. The cells are preferably frozen at a temperature of between −20° C. and to −40° C.
REFERENCES:
patent: 3125096 (1964-03-01), Antiles et al.
patent: 4784133 (1988-11-01), Mackin
patent: 4860744 (1989-08-01), Johnson et al.
patent: 5019042 (1991-05-01), Sahota
patent: 5078713 (1992-01-01), Varney
patent: 5108390 (1992-04-01), Potocky et al.
patent: 5139496 (1992-08-01), Hed
patent: 5147355 (1992-09-01), Friedman et al.
patent: 5190540 (1993-03-01), Lee
patent: 5281215 (1994-01-01), Milder
patent: 5334181 (1994-08-01), Rubinsky et al.
patent: 5334193 (1994-08-01), Nardella
patent: 5335669 (1994-08-01), Tihon et al.
patent: 5342301 (1994-08-01), Saab
patent: 5417689 (1995-05-01), Fine
patent: 5423807 (1995-06-01), Milder
patent: 5443470 (1995-08-01), Stern et al.
patent: 5454807 (1995-10-01), Lennox et al.
patent: 5501681 (1996-03-01), Neuwirth et al.
patent: 5520682 (1996-05-01), Baust et al.
patent: 5536252 (1996-07-01), Imran er al.
patent: 5624392 (1997-04-01), Saab
patent: 5957917 (1999-09-01), Doiron et al.
patent: 5971979 (1999-10-01), Joye et al.
patent: 1019028 (1966-02-01), None
A. Schilling et al., “Nature of the Vehicle for Cryopreservation of Human Peripheral Veins: Preservation of Reactivity to Pharmacological Stimuli”,Cryobiology32, 109-113 (1995).
P. Nataf et al., “Effect of Cold Anoxia and Cryopreservation on Metabolic and Contractile Functions of Human Mammary Artery”,Cryobiology, 32, 327-333 (1995).
Mazur, P., Physical-Chemical Factors Underlying Cell Injury in Cryosurgical Freezing,Cryosurgery, pp. 32-51, published on date even with or prior to Jan. 12, 1999.
Cahan, W., “Five Years of Cryosurgical Experience: Benign and Malignant Tumors with Hemorrhagic Conditions”,Cryosurgery, pp. 388-391, published on date even with or prior to Jan. 12, 1999.
Zacarian, S., “Cryosurgery of Tumors of the Skin and Oral Cavity”, 5 pages, published on date even with or prior to Jan. 12, 1999.
B. Fuller et al., “Clinical Applications of Cryobiology”, 4 pages, published on date even with or prior to Jan. 12, 1999.
G. Morris et al., “Effects of Low Temperatures on Biological Membranes”, 2 pages, published on date even with or prior to Jan. 12, 1999.
R. Coger et al., “Preservation Techniques for Biomaterials”,The Biomedical Engineering Handbook, 8 pages, 1995.
C. Hunt et al., “Fractures in Cryopreserved Arteries”,Cryobiology, 31, 506-515 (1994).
Article entitled “Prostate Cryosurgery now Reimbursable in Southern California”,Healthcare Technology Management, published on date even with or prior to Jan. 12, 1999, 1 page.
Abstract entitled “Renal Cryoablation in a Canine Model”,Urology, May 1996, 1 page.
Abstract entitled “Cox Maze Operation Without Cryoablation for the Treatment of Chronic Atrial Fibrillation”,Annals of Thoracic Surgery, Aug. 1995, 1 page.
Abstract entitled “Percutaneous Serial Catheterization in Swine: a Practical Approach”,Journal of Investigative Surgery, Mar. -Apr. 1995., 1 page.
Abstract entitled “Cardiac Rhythm Disturbances due to Caval Occlusion During Hepatic Cryosurgery”,Cryobiology, Oct. 1994, 1 page.
Abstract entitled “Intractable Chest Pain in Cardiomyopathy: Treatment by a Novel Technique of Cardiac. . .”,British Heart Journal, Dec. 1993, 1 page.
Abstract entitled “Histologic Study of Chronic Catheter Cryoablation of Atrioventricular Conduction in Swine”,American
Crompton Seager and Tufte, LLC
Gibson Roy
Sci-Med Life Systems, Inc.
LandOfFree
Cryoplasty device and method does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Cryoplasty device and method, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Cryoplasty device and method will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-2525929